Winton Group LTD Aeglea Bio Therapeutics, Inc. Transaction History

Winton Group LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$7.23 - $8.55 $95,385 - $112,800	-13,193 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$6.42 - $9.0 $84,699 - $118,737	13,193 New	13,193 $101,000
Q2 2019 Jul 08, 2019	SELL	$6.1 - $8.78 $73,035 - $105,122	-11,973 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$7.6 - $9.4 $90,994 - $112,546	11,973 New	11,973 $96,000

241K

Ticker AGLE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,172,500
Market Cap $1.69B
Description
Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy f...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.